Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 0/25
Result 21,072 decisions over 12 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
26 Dec 2025
10% owner indirect
Sold at will
9,096
$228.95K
0.9%
26 Dec 2025
Director indirect
Bought 2×
16,836
$220.55K
0.2%
26 Dec 2025
Director
Sold at will
50,000
$173.50K
56.1%
26 Dec 2025
10% owner
Bought
13,679
$159.22K
0.2%
26 Dec 2025
10% owner
Sold at will 5×
21,000
$131.44K
1.2%
26 Dec 2025
10% owner
Sold at will
90,709
$110.66K
10.2%
26 Dec 2025
Chief Financial Officer
Bought
1,500
$104.93K
opened
26 Dec 2025
Director
Sold at will
13,105
$104.84K
13.4%
24 Dec 2025
10% owner indirect
Sold at will
1,000,000
$7.50M
26.7%
24 Dec 2025
10% owner indirect
Bought
875,548
$4.05M
3.3%
24 Dec 2025
Pres., Global Field Operations
Sold at will
15,000
$2.95M
6.0%
24 Dec 2025
10% owner
Sold at will
2,629
$2.85M
0.0%
24 Dec 2025
10% owner indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
10% owner indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
10% owner indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
Director indirect
Bought
167,519
$2.65M
2.5%
24 Dec 2025
10% owner indirect
Bought
100,000
$2.48M
0.3%
24 Dec 2025
10% owner indirect
Bought
438,333
$1.93M
7.0%
24 Dec 2025
President & Immunovant CEO
Sold at will
75,000
$1.69M
4.3%
24 Dec 2025
Chief Legal Officer, Secretary
Sold at will
10,000
$1.50M
4.4%
24 Dec 2025
Chairman and CEO
Sold at will 2×
12,400
$1.35M
0.1%
24 Dec 2025
Director
Bought
15,000
$1.08M
2.7%
24 Dec 2025
10% owner indirect
Sold at will
170,000
$375.63K
7.7%
24 Dec 2025
10% owner
Sold at will
170,000
$375.63K
7.7%
24 Dec 2025
Director
Sold at will
10,981
$271.34K
23.7%
24 Dec 2025
10% owner indirect
Sold at will
19,336
$266.06K
0.3%
24 Dec 2025
See Remarks below indirect
Sold at will
55,604
$249.63K
4.4%
24 Dec 2025
10% owner
Sold at will
15,000
$240.75K
0.7%
24 Dec 2025
10% owner
Bought
15,365
$178.23K
0.2%
24 Dec 2025
CEO-First Mid Insurance Group indirect
Sold at will
3,696
$150.00K
93.0%
24 Dec 2025
Chief Executive Officer
Sold at will
16,000
$149.60K
2.0%
24 Dec 2025
Director
Sold at will
5,000
$131.55K
21.3%
23 Dec 2025
President and CEO indirect
Sold at will 12×
100,000
$34.56M
16.8%
23 Dec 2025
10% owner indirect
Bought
2,124,452
$9.65M
8.6%
23 Dec 2025
CFO
Sold at will 2×
406,731
$9.12M
62.9%
23 Dec 2025
10% owner
Bought
1,600
$8.00M
opened
23 Dec 2025
President & Immunovant CEO
Sold at will
200,000
$4.49M
11.0%
23 Dec 2025
10% owner indirect
Bought
225,484
$3.57M
3.4%
23 Dec 2025
10% owner indirect
Bought
225,484
$3.57M
3.4%
23 Dec 2025
10% owner indirect
Bought
225,484
$3.57M
3.4%
23 Dec 2025
Director indirect
Bought
225,484
$3.57M
3.4%
23 Dec 2025
Chief Medical Officer
Sold at will
99,509
$2.75M
95.7%
23 Dec 2025
10% owner indirect
Bought
620,801
$2.72M
11.1%
23 Dec 2025
EVP, Global Business Units
Sold at will
10,000
$2.35M
9.9%
23 Dec 2025
See Remarks
Sold at will 2×
9,548
$1.58M
78.1%
23 Dec 2025
10% owner
Sold at will
100,000
$1.38M
15.2%
23 Dec 2025
10% owner
Bought
112,505
$1.31M
1.5%
23 Dec 2025
10% owner
Sold at will
42,400
$1.10M
1.8%
23 Dec 2025
VICE PRESIDENT
Sold at will
4,000
$1.03M
18.8%
23 Dec 2025
Director indirect
Bought
286,138
$1.01M
opened
Showing 16,401–16,450 of 21,072. ← Newer Page 329 of 422 Older →